Financial statements Bgw Pharma
Balance sheet of Bgw Pharma
Company age:
Age:
3 y. 10 m. 20 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BGW PHARMA
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 1 172 615,95 | 7 298 652,61 |
| A. Fixed assets | 67 558,53 | 257 231,13 |
| B. Current assets | 1 105 057,42 | 7 041 421,48 |
| C. Share capital contributions (basic funds) | 0,00 | - |
| D. Own shares (stocks) | 0,00 | - |
| Total liabilities | 1 172 615,95 | 7 298 652,61 |
| A. Equity | 143 668,83 | 840 201,98 |
| B. Liabilities and provisions for liabilities | 1 028 947,12 | 6 458 450,63 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 1 028 947,12 | 5 486 886,88 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.